- Home
- / CRISPR Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CRISPR Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$48.9
2024-10-29
Market Capitalization
$4.2 B
2024-10-29
Revenue
$3.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.2M | 41.0M | 3.1M | 289.6M | 719.0K | 915.0M | 1.2M | 371.2M | 37.3M | 3.5M |
| General and administrative expense | 31.1M | 35.8M | 48.3M | 63.5M | 88.2M | 102.8M | 102.5M | 76.2M | 73.0M | 73.5M |
| Operating expense total | 73.3M | 105.6M | 162.1M | 242.9M | 355.2M | 541.4M | 564.1M | 463.5M | 393.6M | 358.3M |
| EBIT | (68.1M) | (64.6M) | (158.9M) | 46.7M | (354.4M) | 373.5M | (673.2M) | (222.5M) | (466.6M) | (664.6M) |
| EBIT margin, % | -1319.3% | -157.7% | -5087.8% | 16.1% | -49295.5% | 40.8% | -56190.4% | -60.0% | -1250.4% | -18933.6% |
| Investment income | (36.5M) | (1.8M) | (4.3M) | (5.5M) | ||||||
| Interest income | 104.3M | |||||||||
| Interest expense | 8.1M | |||||||||
| Pre tax profit | (22.7M) | (66.6M) | (164.4M) | 67.3M | (348.1M) | 379.5M | (650.5M) | (150.7M) | (362.7M) | (578.0M) |
| Income tax expense | 484.0K | 1.7M | 553.0K | 448.0K | 809.0K | 1.9M | (325.0K) | 2.9M | 3.6M | 3.6M |
| Net Income | (23.2M) | (68.4M) | (165.0M) | 66.9M | (348.9M) | 377.7M | (650.2M) | (153.6M) | (366.3M) | (581.6M) |
| EPS | 1.2 | (5.3) | 4.7 | (8.4) | (1.9) | (4.3) | (6.5) |